Bortezomib, Melphalan, and Prednisone with or Without Daratumumab in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (Alcyone): Final Analysis of an Open-Label, Randomised, Multicentre, Phase 3 Trial

AuthID
 P-018-K2D
25
Author(s)
Mateos, MV
·
Suzuki, K
·
Jakubowiak, A
·
Knop, S
·
Lucio, P
·
[+1]·
[+2]·
[+1]·
[+1]·
Ngo, M
·
Katz, EG
·
Bolyard, K
·
Carson, R
·
Borgsten, F
·
View all authors
Tipo de Documento
Article
Year published
2025
Publicado
in LANCET ONCOLOGY, ISSN: 1470-2045
Volume: 26, Número: 5, Páginas: 596-608 (13)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 40220771
SCOPUS: 2-s2.0-105002287608
Wos: WOS:001495892100001
Source Identifiers
ISSN: 1470-2045
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Nome   Name Order Nome   Name Order Nome
1 Mateos, MV;   2 San-Miguel, J;   3 Cavo, M;
4 Suzuki, K;   5 Jakubowiak, A;   6 Knop, S;
7 Doyen, C;   8 Lucio, P;   9 Nagy, Z;
10 Pour, L;   11 Grosicki, S;   12 Crepaldi, A;
13 Liberati, AM;   14 Campbell, P;   15 Yoon, SS;
16 Iosava, G;   17 Fujisaki, T;   18 Garg, M;
19 Ngo, M;   20 Katz, EG;   21 Krevvata, M;
22 Bolyard, K;   23 Carson, R;   24 Borgsten, F;
25 Dimopoulos, M;    

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service